Quarterly Result4 Nov 2026, 06:03 pm
Dipna Pharmachem Declares Unaudited Q1 FY27 Results
AI Summary
Dipna Pharmachem Limited has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company adopted IND AS from April 1, 2025. The results were reviewed by the audit committee and approved by the Board of Directors on November 4, 2026. No investor complaints were pending as of June 30, 2026. The company operates in a single segment, Chemicals.
Key Highlights
- Unaudited standalone financial results for Q1 FY27 declared.
- Company adopted IND AS from April 1, 2025.
- Results approved by the Board on November 4, 2026.
- No investor complaints received or pending.
- Company operates in a single Chemicals segment.
Price Impact
More from DPL